Finance

Lists
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
4,33 $
-1,81%
(-0,080) 1D
4,25 $
-1,85% (-0,080)
After hours
Closed: 15 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
4,40 $
High
4,62 $
Low
4,23 $
Mkt. cap
83,75 մլն
Avg. vol.
1,23 մլն
Volume
1,09 մլն
52-wk high
20,56 $
52-wk low
4,23 $
EPS
-6,17 $
Beta
2,63
Shares outstanding
19,34 մլն
No. of employees
36
Open
4,40 $
High
4,62 $
Low
4,23 $
Mkt. cap
83,75 մլն
Avg. vol.
1,23 մլն
Volume
1,09 մլն
52-wk high
20,56 $
52-wk low
4,23 $
EPS
-6,17 $
Beta
2,63
Shares outstanding
19,34 մլն
No. of employees
36
News stories
From web sources and news partners
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
Founded01 հնվ, 2009 թ.
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current 4,33 $
48,00 $ (+1 008,55%)
Average
36,67 $ (+746,88%)
Lowest
30,00 $ (+592,84%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
30,00 $
+592,8%
09/15/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
35,00 $
+708,3%
09/15/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
09/14/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
38,00 $
+777,6%
09/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
33,00 $
+662,1%
09/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
36,00 $
+731,4%
08/12/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
48,00 $
+1 008,5%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
48,00 $
+1 008,5%
08/07/2026
Paul Jeng
Guggenheim
Buy
Maintained
45,00 $
+939,3%
06/02/2026
Unknown Analyst
Wedbush
Buy
Reiterated
38,00 $
+777,6%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
33,00 $
+662,1%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
28,00 $
+546,7%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
20,86 մլն
18,41 մլն
19,82 մլն
31,18 մլն
Cost of revenue
20,86 մլն
18,41 մլն
19,82 մլն
31,18 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,56 մլն
3,56 մլն
4,48 մլն
5,02 մլն
Operating expense
3,56 մլն
3,56 մլն
4,48 մլն
5,02 մլն
Total operating expenses
24,42 մլն
21,97 մլն
24,30 մլն
36,19 մլն
Operating income
-24,42 մլն
-21,97 մլն
-24,30 մլն
-36,19 մլն
Other non operating income
-50,00 հզր
-1,10 մլն
-67,00 հզր
-11,00 հզր
EBT including unusual items
-23,34 մլն
-20,56 մլն
-22,97 մլն
-35,04 մլն
EBT excluding unusual items
-23,34 մլն
-21,66 մլն
-22,97 մլն
-35,04 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23,34 մլն
-20,56 մլն
-22,97 մլն
-35,04 մլն
Net profit margin
-
-
-
-
Earnings per share
-1,90
-1,25
-1,23
-1,81
Interest and investment income
1,12 մլն
1,41 մլն
1,40 մլն
1,16 մլն
Interest expense
-
-
-
-
Net interest expenses
1,12 մլն
1,41 մլն
1,40 մլն
1,16 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-24,37 մլն
-21,92 մլն
-24,26 մլն
-36,14 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps